2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Julio Aguirre-Ghiso, PhD, discusses future research directions being conducted by investigators at the Albert Einstein Cancer Center.
Julio Aguirre-Ghiso, PhD, founding director, Cancer Dormancy and Tumor Microenvironment Institute, director, Gruss-Lipper Biophotonics Center, co-leader, AECC Tumor Microenvironment and Metastasis Program, Albert Einstein Cancer Center, discusses future research directions being conducted by investigators at the Albert Einstein Cancer Center.
In terms of studying the tumor microenvironment, the most significant unmet need is understanding the biology of metastasis, according to Aguirre-Ghiso. The incidence and aggressiveness of metastasis differs based on factors such as race, lifestyle, and diet, and as such, there is still more to understand, Aguirre-Ghiso explains.
For example, determining why African Americans experience more aggressive breast cancer progression or why other ethnic groups seem to have more mild disease will be a focus of future research efforts at the Albert Einstein Cancer Center, Aguirre-Ghiso concludes.
Related Content: